Prevalence of Carbapenem Non-susceptible Gram-Negative Bacteria at Tertiary Care Hospitals in Saudi Arabia

被引:8
|
作者
Aloraifi, Rayan I. [1 ]
Alharthi, Abdullah F. [1 ]
Almefleh, Abdulrahman A. [1 ]
Alamri, Abdulkhaleq H. [1 ]
Alobud, Adi S. [1 ]
Bawazeer, Reema A. [2 ]
Alswaji, Abdulrahman A. [2 ]
Alalwan, Bassam [3 ]
Aldriwesh, Marwh G. [4 ]
Al Johani, Sameera M. [3 ]
Alghoribi, Majed F. [2 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia
[2] King Abdullah Int Med Res Ctr, Infect Dis Res, Riyadh, Saudi Arabia
[3] King Abdul Aziz Med City, Pathol & Lab Med Dept, Microbiol Sect, Riyadh, Saudi Arabia
[4] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Appl Med Sci, Clin Lab Sci, Riyadh, Saudi Arabia
关键词
surveillance; antimicrobial resistance; saudi arabia; antimicrobial resistance surveillance; gram-negative bacteria; carbapenem resistance; ANTIMICROBIAL RESISTANCE; MOLECULAR-MECHANISMS; PATHOGENS;
D O I
10.7759/cureus.33767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Antibiotics significantly increased life expectancy and decreased mortality rates due to infections. However, this trend is starting to fade with the rise of multidrug-resistant organisms (MDR); these strains are becoming a global burden on healthcare and the economy. The dramatic increase and spread of carbapenem-resistant gram-negative bacteria (CRGNB) has become a serious global public health concern. In this retrospective cross-sectional study, we aimed to estimate the rates of gram-negative bacteremia in five tertiary care hospitals in different geographical locations in Saudi Arabia for five years.Methods A retrospective cross-sectional study was conducted in five tertiary care hospitals in Saudi Arabia among patients with bacteremia due to CRGNB. Electronic medical records were used to retrieve data regarding patient demographics and antimicrobial susceptibility testing (AST) over five years between January 2016 and December 2020. Patients with positive blood cultures for carbapenem-resistant Escherichia (E.) coli, Klebsiella (K.) pneumonia, Pseudomonas (P.) aeruginosa, and Acinetobacter (A.) baumannii comprise the final study population.Results This retrospective multicentric study was conducted between 2016 and 2020 in five tertiary care hospitals across five cities in Saudi Arabia. E. coli (n=2190, 38.03%), K. pneumoniae (n=2154, 37.41%), P. aeruginosa (n = 918, 15.94%), and A. baumannii (n=496, 8.61%) constitute the 5758 gram-negative bacteria isolates. E. coli was the most frequently identified species in Riyadh, AlAhsa, Dammam, and Madinah (40%, 46.50%, 61.67%, and 43.66%, respectively), with a p-value of (p<0.001), except in Jeddah, where K. pneumoniae was the most prevalent (42%). The mean age of patients across Riyadh, AlAhsa, Dammam, and Madinah was 62.2 years (+/- 4.24). In contrast to Jeddah, where the majority of isolates (702; 41.8%) belonged to the adult age group. Most isolates were from male patients (3045; 52.9%), compared to 2713 (47.1%) from female patients. K. pneumoniae 1226 (40.3%) was the most prevalent isolate among male patients while E. coli (1135; 41.8%) was the most prevalent isolate among female patients.Conclusion Our study showed that the prevalence of carbapenem non-susceptible Gram-negative bacteria is relatively high, which therefore makes them very challenging to treat. The results show an urgent need for improved antibiotic stewardship strategies, including better surveillance and more effective infection control measures to reduce this issue. Further research into the molecular epidemiology and risk factors associated with these infections is necessary to guide public health policymakers in developing interventions to help control the spread of carbapenem-resistant Gram-negative bacteria.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia
    Alzayer, Maha
    Alghoribi, Majed F.
    Alalwan, Bassam
    Alreheli, Abdualah
    Aljohani, Sameera
    Bosaeed, Mohammad
    Doumith, Michel
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 176 - 180
  • [2] Phenotypic characterization of carbapenem non-susceptible gram-negative bacilli isolated from clinical specimens
    Abdeta, Abera
    Bitew, Adane
    Fentaw, Surafel
    Tsige, Estifanos
    Assefa, Dawit
    Lejisa, Tadesse
    Kefyalew, Yordanos
    Tigabu, Eyasu
    Evans, Martin
    PLOS ONE, 2021, 16 (12):
  • [3] Risk of relapse and readmission among hospitalized adults with carbapenem non-susceptible gram-negative infections
    Dillon, Ryan
    Burton, Tanya
    Anderson, Amy J.
    Seare, Jerry
    Puzniak, Laura
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (06) : 881 - 888
  • [4] Infection with Gram-negative Bacteria among Children at a Tertiary Hospital in Jeddah, Saudi Arabia
    Bamshmous, Yaser Saleh
    Alwagdani, Shahad Mesfer
    Albarakati, Maisa Mubarak
    Alkouwait, Mohammed Jawad
    AlThwebi, Samah Mohamed
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2021, 32 (06) : 1593 - 1599
  • [5] The prevalence of aminoglycoside-resistant genes in Gram-negative bacteria in tertiary hospitals
    Ahmed, Omar B.
    Asghar, Atif H.
    Bahwerth, Fayez S.
    Assaggaf, Hamza M.
    Bamaga, Majid A.
    APPLIED NANOSCIENCE, 2021, 13 (2) : 1093 - 1093
  • [6] Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK)
    Simon D. Goldenberg
    Andrew R. Dodgson
    Gavin Barlow
    Benjamin J. Parcell
    Lim Jones
    Mahableshwar Albur
    A. Peter R. Wilson
    David A. Enoch
    Aleks Marek
    Christianne Micallef
    Davide Manissero
    Christopher Longshaw
    Sara Lopes
    Karan Gill
    Advances in Therapy, 2022, 39 : 3602 - 3615
  • [7] Prevalence of Multidrug-Resistant Gram-Negative Bacteria in Saudi Arabia: Meta Review
    Alshammari, Naheda
    Aly, Magda
    Al-Abdullah, Nabeela
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2021, 14 (01): : 12 - 19
  • [8] Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK)
    Goldenberg, Simon D.
    Dodgson, Andrew R.
    Barlow, Gavin
    Parcell, Benjamin J.
    Jones, Lim
    Albur, Mahableshwar
    Wilson, A. Peter R.
    Enoch, David A.
    Marek, Aleks
    Micallef, Christianne
    Manissero, Davide
    Longshaw, Christopher
    Lopes, Sara
    Gill, Karan
    ADVANCES IN THERAPY, 2022, 39 (08) : 3602 - 3615
  • [9] Four years of experience with carbapenem-resistant Gram-negative bacteria in two tertiary care hospitals in Crete, Greece
    C Tsioutis
    S Karageorgos
    S Stratakou
    E Bolikas
    E Astrinaki
    A Messaritaki
    M Adami
    A Georgiladakis
    A Kassimati
    A Gikas
    Antimicrobial Resistance and Infection Control, 4 (Suppl 1)
  • [10] Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections
    Paoletti, Martina
    Marcellusi, Andrea
    Yang, Joe
    Mennini, Francesco Saverio
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2023, 10 : 18 - 28